HU197201B - Process for producing oral pharmaceutical compositions of controlled solubility of the active components - Google Patents

Process for producing oral pharmaceutical compositions of controlled solubility of the active components Download PDF

Info

Publication number
HU197201B
HU197201B HU864004A HU400486A HU197201B HU 197201 B HU197201 B HU 197201B HU 864004 A HU864004 A HU 864004A HU 400486 A HU400486 A HU 400486A HU 197201 B HU197201 B HU 197201B
Authority
HU
Hungary
Prior art keywords
priority
process according
fatty acid
acid ester
weight ratio
Prior art date
Application number
HU864004A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT44701A (en
Inventor
Othmar Zueger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HUT44701A publication Critical patent/HUT44701A/hu
Publication of HU197201B publication Critical patent/HU197201B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU864004A 1985-10-01 1986-09-19 Process for producing oral pharmaceutical compositions of controlled solubility of the active components HU197201B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUT44701A HUT44701A (en) 1988-04-28
HU197201B true HU197201B (en) 1989-03-28

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
HU864004A HU197201B (en) 1985-10-01 1986-09-19 Process for producing oral pharmaceutical compositions of controlled solubility of the active components

Country Status (20)

Country Link
KR (1) KR920008817B1 (nl)
AT (1) AT402257B (nl)
BE (1) BE905516A (nl)
CA (1) CA1298784C (nl)
CH (1) CH669524A5 (nl)
DE (1) DE3632201C2 (nl)
DK (1) DK170016B1 (nl)
ES (1) ES2002508A6 (nl)
FR (1) FR2589732B1 (nl)
GR (1) GR862457B (nl)
HK (1) HK392A (nl)
HU (1) HU197201B (nl)
IE (1) IE59589B1 (nl)
IL (1) IL80182A (nl)
LU (1) LU86615A1 (nl)
NL (1) NL194822C (nl)
NZ (1) NZ217732A (nl)
PT (1) PT83456B (nl)
SE (1) SE503222C2 (nl)
SG (1) SG103391G (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE409475T1 (de) * 2001-02-20 2008-10-15 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
DK464686D0 (da) 1986-09-29
GR862457B (en) 1987-01-29
HUT44701A (en) 1988-04-28
KR920008817B1 (ko) 1992-10-09
SG103391G (en) 1992-01-17
PT83456B (pt) 1989-05-12
NL194822B (nl) 2002-12-02
IL80182A (en) 1991-01-31
NL8602370A (nl) 1987-05-04
CH669524A5 (nl) 1989-03-31
DE3632201C2 (de) 1997-05-07
CA1298784C (en) 1992-04-14
NL194822C (nl) 2003-04-03
LU86615A1 (fr) 1987-04-02
IL80182A0 (en) 1986-12-31
ES2002508A6 (es) 1988-08-16
AT402257B (de) 1997-03-25
DK464686A (da) 1987-04-02
HK392A (en) 1992-01-10
KR870003777A (ko) 1987-05-04
NZ217732A (en) 1990-07-26
BE905516A (fr) 1987-03-30
IE59589B1 (en) 1994-03-09
SE8604112D0 (sv) 1986-09-29
IE862565L (en) 1987-04-01
SE503222C2 (sv) 1996-04-22
DE3632201A1 (de) 1987-04-02
ATA260486A (de) 1996-08-15
SE8604112L (sv) 1987-04-02
FR2589732B1 (fr) 1989-07-13
FR2589732A1 (fr) 1987-05-15
DK170016B1 (da) 1995-05-01
PT83456A (en) 1986-10-01

Similar Documents

Publication Publication Date Title
DK173033B1 (da) Farmaceutisk præparat med forlænget frigørelse og fremstilling deraf
JP3776931B2 (ja) Ａｃｅ阻害剤ラミプリルとジヒドロピリジン化合物を含有する新規医薬組成物
AU760435B2 (en) Sustained release ranolazine formulations
AU2001240092B2 (en) Sustained release ranolazine formulations
KR950008307B1 (ko) 경구용 항응고제와 혈소판 억제제의 저용량 제형
HU197839B (en) Process for producing metoprolol containing pharmaceutical compositions
AU2001240092A1 (en) Sustained release ranolazine formulations
NZ220769A (en) Compositions of ketotifen (4-(1-methyl-4-piperidylidene)- 4h-benzo(4,5)cyclohepta(1,2-b)thiophen-10-9(h)-one)
RU2213560C2 (ru) Фармацевтическая композиция, содержащая сочетание правовращающего и левовращающего изомеров соталола
GB2154874A (en) Bromocriptine compositions
GB2181053A (en) Controlled release formulation
JPH1192369A (ja) 医薬品調製物、その製造方法及びシランセトロンの安定化のための酸性添加剤の使用
HU197201B (en) Process for producing oral pharmaceutical compositions of controlled solubility of the active components
AU618599B2 (en) Controlled release bromocriptine formulations
AU598751B2 (en) Pharmaceutical formulations with controlled release of the active substance
JPS62149618A (ja) 活性物質放出制御医薬製剤
Epstein Rate Control Versus Rhythm Control for Atrial Fibrillation–Implications of Recent Clinical Trials for Clinical Practice

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HPC4 Succession in title of patentee

Owner name: NOVARTIS AG., CH